Pharmaceutical Technology E-Alert:
Having trouble viewing this e-mail? Click here.
You are subscribed to %%list.name%% as %%emailaddr%%.
Click here to unsubscribe or edit your member profile.
  Pharmaceutical Technology Europe E-Alert
 
17 February 2012

IN THIS ISSUE
FDA guidance
APIs in South Africa
Pharmacogenetics guidance
FDA funding
Twitter


FDA releases Heparin quality draft guidance
In response to the 2008 Heparin incident, the FDA has released a draft guidance on monitoring crude Heparin for quality. More...
 
South Africa plans joint venture for new API plant
The South African government is conducting talks with the Swiss biopharmaceutical company Lonza regarding a joint venture to construct the country’s first plant to manufacture APIs for antiretroviral (ARV) medicines. More...
 
EMA guidance on genetic variability
The EMA has published a guideline that addresses the influence of patients’ genetic variability on drug pharmacokinetics. More...
 
Obama budget includes FDA increases
The US President Barack Obama has released his budget proposal for 2013, which includes a $654-million increase in FDA funding. More...
 
Follow us on Twitter
We tweet regularly about the latest news, trends and rumours hitting the web about the bio/pharma industry. Follow us to make sure you don't miss out! More...
Key Topics:

Latest blog posts
Roche and Illumina ready the trenches
It's here: FDA unveils guidance for biosimilar development
Shrinking economy hits California biotech sector
More blog posts

Latest articles
Report from India
FDA and Justice Department address drug quality concerns
Expanding capabilities in the pharmaceutical cold chain
More articles

Upcoming events
BIO-Europe Spring (19–21 March | The Netherlands)
8th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology (19–22 March | Turkey)
CPhI Japan (21–23 March | Japan)
More events

Products/Service Profiles
Hospira One 2 One

Hospira One 2 One® contract development and fill-finish manufacturing of injectable products packaged in vials, PFS, cartridges, ampoules. Broad range of capabilities: Biologics; Potent drugs; Vaccines; Cytotoxics; Beta-lactams; Lyophilization.
Read more

 
Jones Lang LaSalle

Specialist chemicals plant for sale in Church Village, South Wales.  Clariant Chemicals to dispose of Parabens & Polymer production facility, Jones Lang LaSalle’s Cardiff office instructed to market.
Read more


Event Profile
PDA

Parenteral Packaging, March 13-15, Berlin | Germany
PDA organizes this conference to address the technical and regulatory issues related to parenteral packaging. Chemical, physical and microbiological aspects will be considered and current regulatory challenges will be discussed. Two Training Courses on Container Closure Development or Selection and Utilization of Glass Containers in Pharmaceutical Packaging will be given Read more

 
 
Survey
Which is your preferred social media tool for professional use?
Twitter 10%
 
Facebook 12%
     
LinkedIn 64%
     
Google+ 10%
     
Other 4%

This week we would like to know...

During the past decade, what has been the most significant advance in sterile manufacturing?

Click here to vote

Contact Us
Click here to contact editorial.

Click here to contact sales.

 
You are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile

To ensure delivery to your inbox, please add us to your address book. If you need help doing this, click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact
information available to third parties for marketing purposes, please contact us by emailing [email protected] or by mail
at Advanstar Communications Inc., Bridgegate Pavilion, 4A Chester Business Park, Wrexham Road, Chester, CH4 9QH, UK.